Ann: Appendix 4C - Quarterly, page-23

As small biotech companies go, Orthocell is killing it with 2-6% fluctuations

Im just pissed off with management for not pushing harder for approvals, partnerships, communication is still rubbish. With very little interest from investors, turning over a few hundred thousand shares day in day out is never going to change the share price. I need to see a US partner who is keen to take products commercially, not just talk about it the last five years

We know the share price will jump up to 30% on a good announcement, but I want it to grow from there 50, 60, 80% eventually ticking over 100% and holding, waiting for the next increase